Engineered microbial strain safety assessment helps R&D teams evaluate whether a modified strain matches its intended design and whether genome-level risk signals require further review. At CD Genomics, we support pharma and biotech teams with sequencing, safety-focused bioinformatics, QC review, and clear reporting for internal project decisions.

• Verify engineered strain identity and construct integrity
• Screen AMR, virulence, toxin, and MGE signals
• Assess plasmid, vector, and foreign sequence evidence
• Compare candidate strains with clear reporting